Remove missions
article thumbnail

Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval

Outsourcing Pharma

Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.

article thumbnail

BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production

Fierce Pharma

University of Pennsylvania spinout BlueWhale Bio has surfaced on a mission to smash bottlenecks in cell and gene therapy manufacturing. Cell therapy manufacturer BlueWhale Bio uncloaked Thursday with news it has raised $18 million in seed financing. The funding round was led by Danaher Corporation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mission Therapeutics raises £25.2m to enhance power of mitochondria

BioPharma Reporter

Clinical-stage biotech Mission Therapeutics has raised Â25.2 million to progress clinical development of its mitophagy clinical candidates.

article thumbnail

EQRx's low-price drugs mission ends with Revolution buy

pharmaphorum

EQRx's low-price drugs mission ends with Revolution buy Phil.Taylor Tue, 01/08/2023 - 15:49 Bookmark this

Drugs 94
article thumbnail

Physics professor selected for NASA mission

Scienmag

A space physicist at The University of Texas at Arlington will play a key role in NASA’s Geospace Dynamics Constellation (GDC) mission. Credit: Randy Gentry / The University of Texas at Arlington A space physicist at The University of Texas at Arlington will play a key role in NASA’s Geospace Dynamics Constellation (GDC) mission.

73
article thumbnail

First spaceflight mission for drug development lab

Drug Discovery World

Redwire will launch its in-space pharmaceutical manufacturing platform, PIL-BOX, onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS). The post First spaceflight mission for drug development lab appeared first on Drug Discovery World (DDW).

article thumbnail

Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval

Outsourcing Pharma

Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.